{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T21:38:00Z","timestamp":1785706680590,"version":"3.56.0"},"reference-count":121,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hemophilia, an X-linked bleeding disorder, is characterized by a deficiency in coagulation factors. It manifests as spontaneous bleeding, leading to severe complications if not properly managed. In contrast, acquired hemophilia is an autoimmune condition marked by the development of inhibitory antibodies against coagulation factors. Both forms present significant diagnostic and therapeutic challenges, highlighting the need for advanced genetic, molecular, laboratory, and clinical assessments. Recent advances in artificial intelligence have opened new avenues for the management of hemophilia. Machine learning and deep learning technologies enhance the ability to predict bleeding risks, optimize treatment regimens, and monitor disease progression with greater precision. Artificial intelligence-driven applications in medical imaging have also improved the detection of joint damage and hemarthrosis, ensuring timely interventions and better clinical outcomes. Moreover, the integration of artificial intelligence into clinical practice holds the potential to transform hemophilia care through predictive analytics and personalized medicine, promising not only faster and more accurate diagnoses but also a reduction in long-term complications. However, ethical considerations and the need for data standardization remain critical for its widespread adoption. The application of artificial intelligence in hemophilia represents a paradigm shift towards precision medicine, with the promise of significantly improving patient outcomes and quality of life.<\/jats:p>","DOI":"10.3390\/ijms26136100","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T06:55:13Z","timestamp":1750920913000},"page":"6100","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Artificial Intelligence in the Management of Hereditary and Acquired Hemophilia: From Genomics to Treatment Optimization"],"prefix":"10.3390","volume":"26","author":[{"given":"Laura","family":"Giordano","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Gaetano","family":"Pagana","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3010-3815","authenticated-orcid":false,"given":"Paola Lucia","family":"Minciullo","sequence":"additional","affiliation":[{"name":"Allergy and Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-2640","authenticated-orcid":false,"given":"Manlio","family":"Fazio","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7947-158X","authenticated-orcid":false,"given":"Fabio","family":"Stagno","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[{"name":"Allergy and Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Genovese","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), 98164 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-8239","authenticated-orcid":false,"given":"Alessandro","family":"Allegra","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d, University of Messina, Via Consolare Valeria, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/JBM.S490588","article-title":"Emerging Therapies in Hemophilia: Improving Equitable Access to Care","volume":"16","author":"Lewandowska","year":"2025","journal-title":"J. Blood Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: Communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/jth.15397","article-title":"A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH","volume":"19","author":"James","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede","year":"2020","journal-title":"Haematologica"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/a-1665-6232","article-title":"An Update on Laboratory Diagnostics in Haemophilia A and B","volume":"42","author":"Miesbach","year":"2022","journal-title":"Hamostaseologie"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.trsl.2012.12.016","article-title":"Hemophilia clinical gene therapy: Brief review","volume":"161","author":"Walsh","year":"2013","journal-title":"Transl. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijbiomac.2018.06.084","article-title":"Advancement in the treatment of haemophilia","volume":"118 Pt A","author":"Bhardwaj","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Okaygoun, D., Oliveira, D.D., Soman, S., and Williams, R. (2021). Advances in the management of haemophilia: Emerging treatments and their mechanisms. J. Biomed. Sci., 28.","DOI":"10.1186\/s12929-021-00760-4"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e36823","DOI":"10.2196\/36823","article-title":"Guidelines for Artificial Intelligence in Medicine: Literature Review and Content Analysis of Frameworks","volume":"24","author":"Crossnohere","year":"2022","journal-title":"J. Med. Internet Res."},{"key":"ref_11","first-page":"8830200","article-title":"The recent progress and applications of digital technologies in healthcare: A review","volume":"2020","author":"Senbekov","year":"2020","journal-title":"Int. J. Telemed. Appl."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Stoumpos, A.I., Kitsios, F., and Talias, M.A. (2023). Digital transformation in healthcare: Technology acceptance and its applications. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20043407"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e41138","DOI":"10.2196\/41138","article-title":"Artificial Intelligence in Medicine: Text Mining of Health Care Workers\u2019 Opinions","volume":"25","year":"2023","journal-title":"J. Med. Internet Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.thromres.2013.10.020","article-title":"The history of haemophilia\u2014A short review","volume":"134","author":"Schramm","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.5435\/JAAOS-D-18-00182","article-title":"Recurrent Hemarthrosis After Total Knee Arthroplasty: Evaluation and Treatment","volume":"27","author":"Ravi","year":"2019","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2516.2002.00641.x","article-title":"Haemophilic pseudotumours of the limbs and their percutaneous treatment","volume":"8","author":"Caviglia","year":"2002","journal-title":"Haemophilia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s11910-023-01313-y","article-title":"Neurological Complications Associated with Hereditary Bleeding Disorders","volume":"23","author":"Bhatti","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_19","first-page":"V05220323","article-title":"Haematoma in the airways as the first symptom of acquired haemophilia A","volume":"184","author":"Bick","year":"2022","journal-title":"Ugeskr. Laeger"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/bjh.18085","article-title":"Cardiovascular disease in hereditary haemophilia: The challenges of longevity","volume":"197","author":"Shapiro","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Pasi","year":"2003","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(15)01123-X","article-title":"The past and future of haemophilia: Diagnosis, treatments, and its complications","volume":"388","author":"Peyvandi","year":"2016","journal-title":"Lancet"},{"key":"ref_23","first-page":"575","article-title":"Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy","volume":"12","author":"Rocino","year":"2014","journal-title":"Blood Transfus."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: Updated review of evidence and treatment guidance","volume":"92","author":"Kempton","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/ejh.13592","article-title":"Principles of care for acquired hemophilia","volume":"106","author":"Dolan","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.hoc.2021.07.007","article-title":"Acquired Hemophilia A","volume":"35","author":"Pai","year":"2021","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/hematology.2023000460","article-title":"Diagnosis and laboratory monitoring of acquired hemophilia A","volume":"2023","author":"Platton","year":"2023","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11357-024-01317-7","article-title":"Acquired hemophilia A as a disease of the elderly: A comprehensive review of epidemiology, pathogenesis, and novel therapy","volume":"47","author":"Lehoczki","year":"2025","journal-title":"Geroscience"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.20452\/pamw.2192","article-title":"Acquired hemophilia A: An underdiagnosed, severe bleeding disorder","volume":"124","author":"Zdziarska","year":"2014","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 non-hemophilic patients with inhibitors to Factor VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb. Haemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2141.2003.04162.x","article-title":"Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors","volume":"121","author":"Delgado","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: A 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1055\/s-0029-1245109","article-title":"Twelve years of experience of acquired hemophilia A: Trials and tribulations in South Australia","volume":"35","author":"Tay","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/pbc.22657","article-title":"Acquired hemophilia in pediatrics: A systematic review","volume":"55","author":"Franchini","year":"2010","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2516.2010.02259.x","article-title":"Genetic markers in acquired haemophilia","volume":"16","author":"Oldenburg","year":"2010","journal-title":"Haemophilia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/asheducation-2006.1.432","article-title":"Acquired factor VIII inhibitors: Pathophysiology and treatment","volume":"2006","author":"Ma","year":"2006","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2516.2008.01976.x","article-title":"HLA genotype in patients with acquired haemophilia A","volume":"16","author":"Pavlova","year":"2010","journal-title":"Haemophilia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1182\/blood-2012-02-408930","article-title":"Management of bleeding in acquired hemophilia A: Results from the European Acquired Haemophilia (EACH2) registry","volume":"120","author":"Baudo","year":"2012","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood-2012-02-409185","article-title":"Immunosuppression for acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2)","volume":"120","author":"Collins","year":"2012","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MBC.0b013e32832ca388","article-title":"The prognosis and treatment of acquired hemophilia: A systematic review and meta-analysis","volume":"20","author":"Bitting","year":"2009","journal-title":"Blood Coagul. Fibrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/jth.13304","article-title":"Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: Data from the GTH-AH 01\/2010 study","volume":"14","author":"Werwitzke","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0034-1390004","article-title":"Laboratory diagnosis of acquired hemophilia A: Limitations, consequences, and challenges","volume":"40","author":"Tiede","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjh.12091","article-title":"Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia","volume":"160","author":"Collins","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2008.001743","article-title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","volume":"94","author":"Baudo","year":"2009","journal-title":"Haematologica"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1111\/hae.14546","article-title":"Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHC","volume":"28","author":"Miesbach","year":"2022","journal-title":"Haemophilia"},{"key":"ref_47","first-page":"231","article-title":"Hemophilia Gene Therapy: Another Blessing or Another Curse?","volume":"121","author":"Puetz","year":"2024","journal-title":"Mo. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/asheducation.V2012.1.369.3798356","article-title":"Therapeutic challenges in acquired factor VIII deficiency","volume":"2012","author":"Collins","year":"2012","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/hae.12627","article-title":"Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A","volume":"21","author":"Greist","year":"2015","journal-title":"Haemophilia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/j.1538-7836.2007.02755.x","article-title":"Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A","volume":"5","author":"Hvas","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1046\/j.1538-7836.2003.00450.x","article-title":"Monitoring the bioavailability of FEIBA with a thrombin generation assay","volume":"1","author":"Varadi","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1744-9987.2008.00618.x","article-title":"A case report of plasma exchange, steroids, mycophenolate mofetil and cyclophosphamide in acquired factor VIII inhibitors","volume":"12","author":"Rech","year":"2008","journal-title":"Ther. Apher. Dial."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1365-2516.2009.02008.x","article-title":"Postpartum acquired haemophilia: A single centre experience with rituximab","volume":"15","author":"Dedeken","year":"2009","journal-title":"Haemophilia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cac2.12012","article-title":"Emerging role of deep learning-based artificial intelligence in tumor pathology","volume":"40","author":"Jiang","year":"2020","journal-title":"Cancer Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4103\/ijc.IJC_399_20","article-title":"Artificial intelligence in cancer diagnostics and therapy: Current perspectives","volume":"58","author":"Majumder","year":"2021","journal-title":"Indian J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0039-1677913","article-title":"Health Information Management: Implications of Artificial Intelligence on Healthcare Data and Information Management","volume":"28","author":"Stanfill","year":"2019","journal-title":"Yearb. Med. Inform."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: Machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol. Divers."},{"key":"ref_58","first-page":"Doc54","article-title":"Generative AI (gAI) in medical education: Chat-GPT and co","volume":"40","author":"Moritz","year":"2023","journal-title":"GMS J. Med. Educ."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Allegra, A., Tonacci, A., Sciaccotta, R., Genovese, S., Musolino, C., Pioggia, G., and Gangemi, S. (2022). Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection. Cancers, 14.","DOI":"10.3390\/cancers14030606"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Allegra, A., Mirabile, G., Tonacci, A., Genovese, S., Pioggia, G., and Gangemi, S. (2023). Machine Learning Approaches in Diagnosis, Prognosis and Treatment Selection of Cardiac Amyloidosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065680"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Stagno, F., Russo, S., Murdaca, G., Mirabile, G., Alvaro, M.E., Nasso, M.E., Zemzem, M., Gangemi, S., and Allegra, A. (2025). Utilization of Machine Learning in the Prediction, Diagnosis, Prognosis, and Management of Chronic Myeloid Leukemia. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26062535"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Stagno, F., Mirabile, G., Rizzotti, P., Bottaro, A., Pagana, A., Gangemi, S., and Allegra, A. (2025). Using Artificial Intelligence to Enhance Myelodysplastic Syndrome Diagnosis, Prognosis, and Treatment. Biomedicines, 13.","DOI":"10.3390\/biomedicines13040835"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1007\/s00432-023-04667-5","article-title":"An overview and a roadmap for artificial intelligence in hematology and oncology","volume":"149","author":"Altenbuchinger","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_64","first-page":"e2300021","article-title":"Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology","volume":"7","author":"Sala","year":"2023","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"200121","DOI":"10.1016\/j.sasc.2024.200121","article-title":"Integrating convolutional neural networks for microscopic image analysis in acute lymphoblastic leukemia classification: A deep learning approach for enhanced diagnostic precision","volume":"6","author":"Alim","year":"2024","journal-title":"Syst. Soft Comput."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00167-022-07233-7","article-title":"Unsupervised machine learning methods and emerging applications in healthcare","volume":"31","author":"Eckhardt","year":"2023","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bjh.16915","article-title":"Machine learning and artificial intelligence in haematology","volume":"192","author":"Shouval","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.blre.2022.101019","article-title":"Artificial intelligence in hematological diagnostics, Game changer or gadget?","volume":"58","author":"Walter","year":"2023","journal-title":"Blood Rev."},{"key":"ref_69","first-page":"e36490","article-title":"A Review of Artificial Intelligence Applications in Hematology Management, Current Practices and Future Prospects","volume":"24","author":"Elomri","year":"2022","journal-title":"J. Med. Int. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11899-020-00575-4","article-title":"Artificial Intelligence in Hematology: Current Challenges and Opportunities","volume":"15","author":"Radakovich","year":"2020","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2022.02.011","article-title":"Applications of machine learning in routine laboratory medicine, Current state and future directions","volume":"103","author":"Rabbani","year":"2022","journal-title":"Clin. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/hae.13287","article-title":"The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation","volume":"23","author":"Hay","year":"2017","journal-title":"Haemophilia"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jval.2018.03.008","article-title":"Development and validation of an algorithm for identifying patients with hemophilia A in an administrative claims database","volume":"21","author":"Lyons","year":"2018","journal-title":"Value Health"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10928-019-09637-4","article-title":"Routine clinical care data for population pharmacokinetic modeling: The case for Fanhdi\/Alphanate in hemophilia A patients","volume":"46","author":"Chelle","year":"2019","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1016\/j.ygeno.2020.09.020","article-title":"Machine learning method using position-specific mutation based classification outperforms one hot coding for disease severity prediction in haemophilia \u2018A\u2019","volume":"112","author":"Singh","year":"2020","journal-title":"Genomics"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.thromres.2023.10.012","article-title":"Machine learning model for predicting physical activity related bleeding risk in Chinese boys with haemophilia A","volume":"232","author":"Ai","year":"2023","journal-title":"Thromb. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2023.02.016","article-title":"Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes","volume":"225","author":"Li","year":"2023","journal-title":"Thromb. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/bjh.16490","article-title":"Product type and the risk of inhibitor development in nonsevere haemophilia A patients: A case-control study","volume":"189","author":"Eckhardt","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bjh.13131","article-title":"A large-scale computational study of inhibitor risk in non-severe haemophilia A","volume":"168","author":"Shepherd","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/psp4.12808","article-title":"Deep compartment models: A deep learning approach for the reliable prediction of time-series data in pharmacokinetic modeling","volume":"11","author":"Janssen","year":"2022","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/psp4.12828","article-title":"Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling","volume":"11","author":"Janssen","year":"2022","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/jth.13711","article-title":"Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: Results of the INSIGHT case-control study","volume":"15","author":"Eckhardt","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1055\/s-0041-1739514","article-title":"Predictive modeling identifies total bleeds at 12-weeks Postswitch to N8-GP prophylaxis as a predictor of treatment response","volume":"122","author":"Chowdary","year":"2022","journal-title":"Thromb. Haemost."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/hae.13444","article-title":"Effectiveness of the Medtep Hemophilia online platform for adherence to prophylactic treatment in haemophilia patients: Results from a 1-year observational study","volume":"24","year":"2018","journal-title":"Haemophilia"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-0038-1676128","article-title":"Impact of telemedicine tools on record keeping and compliance in haemophilia care","volume":"39","author":"Banchev","year":"2019","journal-title":"Hamostaseologie"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0038-1675575","article-title":"Smart Medication\u2122, an electronic diary for surveillance of haemophilia home care and optimization of resource distribution","volume":"39","author":"Mondorf","year":"2019","journal-title":"Hamostaseologie"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/hae.14869","article-title":"Does the method of telehealth delivery affect the physiotherapy management of adults with bleeding disorders? A comparison of audioconferencing and videoconferencing","volume":"29","author":"Russell","year":"2023","journal-title":"Haemophilia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/hae.14178","article-title":"Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary","volume":"26","author":"Tiede","year":"2020","journal-title":"Haemophilia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1043454215607340","article-title":"Telehealth videoconferencing for children with hemophilia and their families: A clinical project","volume":"33","author":"Jacobson","year":"2016","journal-title":"J. Pediatr. Oncol. Nurs."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e30797","DOI":"10.2196\/30797","article-title":"User-centered development and testing of the online patientreported outcomes, burdens, and experiences (PROBE) survey and the myPROBE app and integration with the Canadian bleeding disorder registry: Mixed methods study","volume":"9","author":"Germini","year":"2022","journal-title":"JMIR Hum. Factors"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/hae.14815","article-title":"Design, development and usability of an educational AI chatbot for people with haemophilia in Senegal","volume":"29","author":"Diop","year":"2023","journal-title":"Haemophilia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/hae.14517","article-title":"Altered neural control of gait and its association with pain and joint impairment in adults with haemophilic arthropathy: Clinical and methodological implications","volume":"28","author":"Maas","year":"2022","journal-title":"Haemophilia"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1055\/a-2415-8646","article-title":"Digital Technologies in Hereditary Coagulation Disorders: A Systematic Review","volume":"44","author":"Kahl","year":"2024","journal-title":"Hamostaseologie"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.jtha.2024.04.019","article-title":"Application of machine learning approaches for predicting hemophilia A severity","volume":"22","author":"Rawal","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jtha.2024.12.030","article-title":"Applying artificial intelligence to uncover the genetic landscape of coagulation factors","volume":"23","author":"Asselta","year":"2025","journal-title":"J. Thromb. Haemost."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Lopes, T.J.S., Rios, R., Nogueira, T., and Mello, R.F. (2021). Protein residue network analysis reveals fundamental properties of the human coagulation factor VIII. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-92201-3"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Lopes, T.J.S., Rios, R., Nogueira, T., and Mello, R.F. (2021). Prediction of hemophilia A severity using a small-input machine-learning framework. NPJ Syst. Biol. Appl., 7.","DOI":"10.1038\/s41540-021-00183-9"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ferreira, M.V., Nogueira, T., Rios, R.A., and Lopes, T.J.S. (2023). A graph-based machine learning framework identifies critical properties of FVIII that lead to hemophilia A. Front. Bioinform., 3.","DOI":"10.3389\/fbinf.2023.1152039"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e16331","DOI":"10.1016\/j.heliyon.2023.e16331","article-title":"A machine learning approach for identifying variables associated with risk of developing neutralizing antidrug antibodies to factor VIII","volume":"9","author":"Rawal","year":"2023","journal-title":"Heliyon"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Lopes, T.J.S., Nogueira, T., and Rios, R. (2022). A machine learning framework predicts the clinical severity of hemophilia B caused by point-mutations. Front. Bioinform., 2.","DOI":"10.3389\/fbinf.2022.912112"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Ferreira-Martins, A.J., Castaldoni, R., Alencar, B.M., Ferreira, M.V., Nogueira, T., Rios, R.A., and Lopes, T.J.S. (2023). Full-scale network analysis reveals properties of the FV protein structure organization. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-36528-z"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"102439","DOI":"10.1016\/j.rpth.2024.102439","article-title":"Artificial intelligence-assisted ultrasound imaging in hemophilia: Research, development, and evaluation of hemarthrosis and synovitis detection","volume":"8","author":"Nagao","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S1470-2045(19)30154-8","article-title":"Digital pathology and artificial intelligence","volume":"20","author":"Niazi","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41379-021-00919-2","article-title":"Digital pathology and artificial intelligence in translational medicine and clinical practice","volume":"35","author":"Baxi","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/17474086.2022.2114895","article-title":"The current role of artificial intelligence in hemophilia","volume":"15","year":"2022","journal-title":"Expert Rev. Hematol."},{"key":"ref_106","first-page":"e66810","article-title":"Application of Artificial Intelligence and Machine Learning Was Not Able to Reliably Predict Poor Outcomes in People with Hemophilia","volume":"16","author":"Hu","year":"2024","journal-title":"Cureus"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e18477","DOI":"10.2196\/18477","article-title":"Reinforcement Learning for Clinical Decision Support in Critical Care: Comprehensive Review","volume":"22","author":"Liu","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"ref_108","first-page":"1334","article-title":"Emicizumab: The hemophilia A game-changer","volume":"109","author":"Mannucci","year":"2024","journal-title":"Haematologica"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.2020006315","article-title":"Emicizumab for the treatment of acquired hemophilia A","volume":"137","author":"Knoebl","year":"2021","journal-title":"Blood"},{"key":"ref_110","first-page":"549","article-title":"Emicizumab in acquired hemophilia A: Pros and cons of a new approach to the prevention and treatment of bleeding","volume":"21","author":"Pasca","year":"2023","journal-title":"Blood Transfus."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa1803550","article-title":"Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors","volume":"379","author":"Mahlangu","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMoa2104205","article-title":"Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A","volume":"385","author":"George","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e57628","DOI":"10.2196\/57628","article-title":"Human Factors, Human-Centered Design, and Usability of Sensor-Based Digital Health Technologies: Scoping Review","volume":"26","author":"Tandon","year":"2024","journal-title":"J. Med. Internet Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/ejh.14056","article-title":"How can artificial intelligence help rehabilitation programs for people with hemophilia in the coming decades?","volume":"111","author":"Tapia","year":"2023","journal-title":"Eur. J. Haematol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2516.2003.00807.x","article-title":"Psychological aspects and coping in haemophilic patients: A case-control study","volume":"9","author":"Canclini","year":"2003","journal-title":"Haemophilia"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2516.2012.02863.x","article-title":"Prevalence of depression in adults with haemophilia","volume":"18","author":"Iannone","year":"2012","journal-title":"Haemophilia"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/hae.13078","article-title":"Physician trust and depression influence adherence to factor replacement: A single-centre cross-sectional study","volume":"23","author":"Tran","year":"2017","journal-title":"Haemophilia"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.aax2342","article-title":"Dissecting racial bias in an algorithm used to manage the health of populations","volume":"366","author":"Obermeyer","year":"2019","journal-title":"Science"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/HYPERTENSIONAHA.120.16340","article-title":"Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?","volume":"77","author":"Vlahou","year":"2021","journal-title":"Hypertension"},{"key":"ref_120","first-page":"76","article-title":"Balancing Security and Privacy: Web Bot Detection, Privacy Challenges, and Regulatory Compliance under the GDPR and AI Act","volume":"5","author":"Vranckaert","year":"2025","journal-title":"Open Res. Eur."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"695","DOI":"10.47102\/annals-acadmedsg.2023103","article-title":"Artificial intelligence in medicine: Ethical, social and legal perspectives","volume":"52","author":"Sung","year":"2023","journal-title":"Ann. Acad. Med. Singap."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6100\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:58:26Z","timestamp":1760032706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":121,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26136100"],"URL":"https:\/\/doi.org\/10.3390\/ijms26136100","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}